(Total Views: 263)
Posted On: 05/18/2017 6:32:08 AM
Post# of 25491
$CBIS expects their suppository regimens to help address a significant demand for cannabinoid-based medicines targeting several patient-specific indications.
(0)
(0)
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!
